These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1667610)

  • 1. Genetic influences in opioid analgesic sensitivity in mice.
    Pick CG; Cheng J; Paul D; Pasternak GW
    Brain Res; 1991 Dec; 566(1-2):295-8. PubMed ID: 1667610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone benzoylhydrazone (NalBzoH) analgesia.
    Paul D; Levison JA; Howard DH; Pick CG; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1990 Nov; 255(2):769-74. PubMed ID: 2173757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D; Pick CG; Tive LA; Pasternak GW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effect of mu- and kappa-opioid agonists in beige and CXBK mice.
    Muraki T; Oike N; Shibata Y; Nomoto T
    J Pharm Pharmacol; 1991 Mar; 43(3):210-2. PubMed ID: 1675282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in mice.
    Kavaliers M; Ossenkopp KP
    Peptides; 1986; 7(3):449-53. PubMed ID: 3022253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid analgesia is dependent on serotonergic mechanisms.
    Vonvoigtlander PF; Lewis RA; Neff GL
    J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
    Price M; Gistrak MA; Itzhak Y; Hahn EF; Pasternak GW
    Mol Pharmacol; 1989 Jan; 35(1):67-74. PubMed ID: 2536470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist.
    Kolesnikov YA; Ferkany J; Pasternak GW
    Life Sci; 1993; 53(19):1489-94. PubMed ID: 8412512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective antagonism of opioid analgesia by a sigma system.
    Chien CC; Pasternak GW
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
    Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
    Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.